139 related articles for article (PubMed ID: 36208043)
21. Elevated Serum Interleukin-34 Level in Patients with Systemic Lupus Erythematosus Is Associated with Disease Activity.
Xie HH; Shen H; Zhang L; Cui MY; Xia LP; Lu J
Sci Rep; 2018 Feb; 8(1):3462. PubMed ID: 29472590
[TBL] [Abstract][Full Text] [Related]
22. The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus.
Thanadetsuntorn C; Ngamjanyaporn P; Setthaudom C; Hodge K; Saengpiya N; Pisitkun P
Sci Rep; 2018 Feb; 8(1):2620. PubMed ID: 29422675
[TBL] [Abstract][Full Text] [Related]
23. IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity.
Ye L; Ji L; Wen Z; Zhou Y; Hu D; Li Y; Yu T; Chen B; Zhang J; Ding L; Du J; Huang Z
J Transl Med; 2014 Mar; 12():69. PubMed ID: 24629023
[TBL] [Abstract][Full Text] [Related]
24. The association between serum prolactin levels and interleukin-6 and systemic lupus erythematosus activity.
Wan Asyraf WA; Mohd Shahrir MS; Asrul W; Norasyikin AW; Hanita O; Kong WY; Azmi MT
Reumatismo; 2018 Dec; 70(4):241-250. PubMed ID: 30570242
[TBL] [Abstract][Full Text] [Related]
25. Do high sensitivity C-reactive protein and serum interleukin-6 levels correlate with disease activity in systemic lupus erythematosuspatients?
Umare V; Nadkarni A; Nadkar M; Rajadhyksha A; Khadilkar P; Ghosh K; Pradhan VD
J Postgrad Med; 2017; 63(2):92-95. PubMed ID: 27531690
[TBL] [Abstract][Full Text] [Related]
26. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus.
Chun HY; Chung JW; Kim HA; Yun JM; Jeon JY; Ye YM; Kim SH; Park HS; Suh CH
J Clin Immunol; 2007 Sep; 27(5):461-6. PubMed ID: 17587156
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Serum β2-microglobulin in Egyptian Patients with Systemic Lupus Erythematosus.
Abd-Elbaky NM; Albeltagy ES; Hammour AE; Ibrahim AS
Egypt J Immunol; 2019 Jul; 26(2):143-153. PubMed ID: 31926503
[TBL] [Abstract][Full Text] [Related]
28. Increased IL-18 in patients with systemic lupus erythematosus: relations with Th-1, Th-2, pro-inflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with pro-inflammatory cytokines.
Amerio P; Frezzolini A; Abeni D; Teofoli P; Girardelli CR; De Pità O; Puddu P
Clin Exp Rheumatol; 2002; 20(4):535-8. PubMed ID: 12175109
[TBL] [Abstract][Full Text] [Related]
29. Monitoring Disease Activity in Systemic Lupus Erythematosus With Single-Molecule Array Digital Enzyme-Linked Immunosorbent Assay Quantification of Serum Interferon-α.
Mathian A; Mouries-Martin S; Dorgham K; Devilliers H; Barnabei L; Ben Salah E; Cohen-Aubart F; Garrido Castillo L; Haroche J; Hie M; Pineton de Chambrun M; Miyara M; Sterlin D; Pha M; Lê Thi Huong D; Rieux-Laucat F; Rozenberg F; Gorochov G; Amoura Z
Arthritis Rheumatol; 2019 May; 71(5):756-765. PubMed ID: 30507062
[TBL] [Abstract][Full Text] [Related]
30. Caffeine intake influences disease activity and clinical phenotype in systemic lupus erythematosus patients.
Orefice V; Ceccarelli F; Barbati C; Lucchetti R; Olivieri G; Cipriano E; Natalucci F; Perricone C; Spinelli FR; Alessandri C; Valesini G; Conti F
Lupus; 2020 Oct; 29(11):1377-1384. PubMed ID: 32703116
[TBL] [Abstract][Full Text] [Related]
31. Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE.
Tripathy R; Panda AK; Das BK
Lupus; 2015 Jan; 24(1):82-9. PubMed ID: 25253568
[TBL] [Abstract][Full Text] [Related]
32. Serum aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1), a novel disease activity predictive biomarker of systemic lupus erythematosus.
Ahn SS; Hong SH; Park Y; Jung SM; Song JJ; Park YB; Lee SW; Park SG
Clin Exp Rheumatol; 2018; 36(4):533-539. PubMed ID: 29352840
[TBL] [Abstract][Full Text] [Related]
33. Urine and serum interleukin 35 as potential biomarkers of lupus nephritis.
Nassif MA
Cent Eur J Immunol; 2021; 46(3):351-359. PubMed ID: 34764807
[TBL] [Abstract][Full Text] [Related]
34. Measurement of serum interferon alpha in Egyptian patients with systemic lupus erythematosus and evaluation of its effect on disease activity: a case-control study.
Fayed A; El Menyawi MM; Ghanema M; Shaker O; Elgohary R
Reumatismo; 2020 Nov; 72(3):145-153. PubMed ID: 33213127
[TBL] [Abstract][Full Text] [Related]
35. Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus.
Mok MY; Huang FP; Ip WK; Lo Y; Wong FY; Chan EY; Lam KF; Xu D
Rheumatology (Oxford); 2010 Mar; 49(3):520-7. PubMed ID: 20026564
[TBL] [Abstract][Full Text] [Related]
36. Serum Amyloid A: A Potential Biomarker Assessing Disease Activity in Systemic Lupus Erythematosus.
Wang CM; Deng JH; Mao GF; He YL; Shi X
Med Sci Monit; 2020 Jun; 26():e923290. PubMed ID: 32584794
[TBL] [Abstract][Full Text] [Related]
37. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
38. Galectin-9 as a biomarker for disease activity in systemic lupus erythematosus.
Matsuoka N; Fujita Y; Temmoku J; Furuya MY; Asano T; Sato S; Matsumoto H; Kobayashi H; Watanabe H; Suzuki E; Kozuru H; Yastuhashi H; Migita K
PLoS One; 2020; 15(1):e0227069. PubMed ID: 31986153
[TBL] [Abstract][Full Text] [Related]
39. Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity.
Houssiau FA; Lefebvre C; Vanden Berghe M; Lambert M; Devogelaer JP; Renauld JC
Lupus; 1995 Oct; 4(5):393-5. PubMed ID: 8563734
[TBL] [Abstract][Full Text] [Related]
40. Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus.
Davas EM; Tsirogianni A; Kappou I; Karamitsos D; Economidou I; Dantis PC
Clin Rheumatol; 1999; 18(1):17-22. PubMed ID: 10088943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]